BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 9461298)

  • 1. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases.
    d'Ortho MP; Will H; Atkinson S; Butler G; Messent A; Gavrilovic J; Smith B; Timpl R; Zardi L; Murphy G
    Eur J Biochem; 1997 Dec; 250(3):751-7. PubMed ID: 9461298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP).
    Stracke JO; Fosang AJ; Last K; Mercuri FA; Pendás AM; Llano E; Perris R; Di Cesare PE; Murphy G; Knäuper V
    FEBS Lett; 2000 Jul; 478(1-2):52-6. PubMed ID: 10922468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
    Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
    J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA.
    Matsumoto S; Katoh M; Saito S; Watanabe T; Masuho Y
    Biochim Biophys Acta; 1997 Nov; 1354(2):159-70. PubMed ID: 9396633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 45 kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases.
    Stanton H; Ung L; Fosang AJ
    Biochem J; 2002 May; 364(Pt 1):181-90. PubMed ID: 11988091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.
    Knäuper V; Will H; López-Otin C; Smith B; Atkinson SJ; Stanton H; Hembry RM; Murphy G
    J Biol Chem; 1996 Jul; 271(29):17124-31. PubMed ID: 8663255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) Is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen.
    Wang P; Nie J; Pei D
    J Biol Chem; 2004 Dec; 279(49):51148-55. PubMed ID: 15381707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2.
    Lichte A; Kolkenbrock H; Tschesche H
    FEBS Lett; 1996 Nov; 397(2-3):277-82. PubMed ID: 8955363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity.
    Mercuri FA; Maciewicz RA; Tart J; Last K; Fosang AJ
    J Biol Chem; 2000 Oct; 275(42):33038-45. PubMed ID: 11032846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan.
    Büttner FH; Hughes CE; Margerie D; Lichte A; Tschesche H; Caterson B; Bartnik E
    Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):159-65. PubMed ID: 9639575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum.
    Lark MW; Williams H; Hoernner LA; Weidner J; Ayala JM; Harper CF; Christen A; Olszewski J; Konteatis Z; Webber R
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):245-52. PubMed ID: 7717983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis.
    Sato H; Seiki M
    J Biochem; 1996 Feb; 119(2):209-15. PubMed ID: 8882706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25).
    English WR; Velasco G; Stracke JO; Knäuper V; Murphy G
    FEBS Lett; 2001 Feb; 491(1-2):137-42. PubMed ID: 11226436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form.
    Stanton H; Gavrilovic J; Atkinson SJ; d'Ortho MP; Yamada KM; Zardi L; Murphy G
    J Cell Sci; 1998 Sep; 111 ( Pt 18)():2789-98. PubMed ID: 9718371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
    Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
    Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
    Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
    EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity.
    Pei D; Weiss SJ
    J Biol Chem; 1996 Apr; 271(15):9135-40. PubMed ID: 8621565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein.
    Chandler S; Cossins J; Lury J; Wells G
    Biochem Biophys Res Commun; 1996 Nov; 228(2):421-9. PubMed ID: 8920930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules.
    Ohuchi E; Imai K; Fujii Y; Sato H; Seiki M; Okada Y
    J Biol Chem; 1997 Jan; 272(4):2446-51. PubMed ID: 8999957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
    Kolkenbrock H; Essers L; Ulbrich N; Will H
    Biol Chem; 1999 Sep; 380(9):1103-8. PubMed ID: 10543448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.